Latham & Watkins represented Autograph in the transaction. Autograph, the Web3 brand pioneering a new era of digital experiences, announced the closing of a series B funding...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe advised Salesforce Ventures on the deal. Willkie advised Insight Partners, while Latham & Watkins advised Index Ventures. Sylvera raised $32.6 million in a...
You must be a Standard 1 Year member to access this content.
Sullivan & Cromwell and Mijares, Angoitia, Cortés y Fuentes advised Sempra Infraestructure Partners on the offering. Latham & Watkins and Creel, García-Cuéllar, Aiza y Enríquez advised...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented OpenSea, while Goodwin represented Dharma Labs in the transaction. OpenSea, an nonfungible token (NFT) marketplace, has announced that it is acquiring Dharma Labs....
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Plaid in the transaction. Plaid executed the acquisition of Cognito, an identity verification and compliance (KYC, AML) platform that makes it faster, easier,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented SoftBank Vision Fund 2 in the transaction. Big Health, a digital therapeutics company dedicated to helping millions get back to good mental health,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins, Paul, Weiss, Herzog Fox & Neeman, Shartsis Friese, and Poultan & Yordan acted on the deal. Chess.com, the world’s largest chess platform, has...
You must be a Standard 1 Year member to access this content.
Gernandt & Danielsson and Norton Rose Fulbright advised Modern Times Group MTG AB (MTG) on the deal. Hannes Snellman advised Savvy Gaming Group. Latham & Watkins...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Arcutis in the transaction. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing novel innovations in immuno-dermatology, has announced that...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Silver Spike Acquisition Corp. II on the deal, while Latham & Watkins represented Eleusis. Silver Spike Acquisition Corp. II announced its approximately $446...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Coherus in the transaction. Coherus BioSciences, Inc. (Coherus or the Company) (Nasdaq: CHRS) has entered into a loan agreement with investment funds managed...
You must be a Standard 1 Year member to access this content.
Norton Rose Fulbright US LLP and Norton Rose Fulbright Canada LLP (transaction counsel) and Davies Ward Phillips & Vineberg LLP and Cravath, Swaine & Moore LLP...
You must be a Standard 1 Year member to access this content.
